Study record

Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans

von Walden F, Fernandez-Gonzalo R, Norrbom J et al. · J Appl Physiol (1985) · 2021

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured circulating mitochondrial-derived peptides before and after acute exercise in healthy adults and found that plasma humanin rose significantly after endurance but not resistance exercise, while MOTS-c showed only a trend towards an increase after endurance exercise. Resting MOTS-c correlated with humanin levels and age but not with fitness measures.

Limitations

Small groups of ten participants each, single acute exercise bouts with short follow-up sampling, and MOTS-c changes that did not reach significance; participant sex distribution is not stated in the abstract.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedHealthy participants randomised to acute endurance cycling, acute resistance exercise or a non-exercising control condition
Populationhealthy adults familiarised to the exercise protocols
DesignRandomised acute exercise intervention; MOTS-c measured
Sample size as reported30 participants (10 endurance, 10 resistance, 10 control)
Control groupnon-exercising control group
Route (data field only)Not reported
Endpoints measuredplasma MOTS-c; plasma humanin; skeletal muscle MOTS-c; exercise-related gene expression; mtDNA copy number
Pathways measuredSIRT1 / PGC-1α / biogenesis
Research areasExercise · Mitochondrial biology · Skeletal muscle
Evidence tierB — Other human study
Publication typesJournal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.